Home › NDC Lookup › Ingredients › Adenoviren Nosode, Cytomegalovirus Nosod... › 43742-2123-01
🧴image loading
(from DailyMed)

Vir Combination Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; 5 18 [hp_X]/mL; 1 12 [hp_X]/mL; 2 12 [hp_X]/mL; 4 16 [hp_C]/mL; 33 [hp_X]/mL; 6 Liquid, 30 mL — NDC 43742-2123-1 (Billing 43742-2123-01) · Product 43742-2123

by Deseret Biologicals, Inc. · 30 mL in 1 BOTTLE, DROPPER (43742-2123-1)

NDC 43742-2123-1 (billing 43742-2123-01) is a package of 30 mL of Vir Combination Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; 5 18 [hp_X]/mL; 1 12 [hp_X]/mL; 2 12 [hp_X]/mL; 4 16 [hp_C]/mL; 33 [hp_X]/mL; 6 Liquid from Deseret Biologicals, Inc., marketed since Jan 2024 and currently FDA-listed, this package's marketing is listed to end Mar 2029. It is the main listing for product NDC 43742-2123, its only package size.

NDC 43742-2123-01
🏷️ FDA NDC (as labeled) 43742-2123-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 43742-2123-1
Product NDC 43742-2123
11-digit billing NDC 43742212301
UNII FKD3DUK39I, 7COI029E6K, 22G38P19RL, 74J6DNH49U, 2A26YW7PNX, 77H9EM77P7 +5 more
UPC 0810151884202
SPL Set ID 382d5062-5da5-4fd9-a39b-367ff9d88d87
Established class (EPC) Live Human Adenovirus Type 4 Vaccine; Vaccines; Live
Physiologic effect Actively Acquired Immunity
Chemical class Adenovirus; Unattenuated
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-01-25
Marketing end 2029-03-20
Route ORAL
Dosage form LIQUID
Substance HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEH
Quick answers for NDC 43742-2123-1
  • 11-digit billing NDC: 43742212301
Why two NDCs? The FDA registers this code as 43742-2123-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 43742-2123-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an unapproved homeopathic liquid product taken by mouth that contains highly diluted forms of viral agents, including adenovirus, hepatitis B virus, herpes simplex viruses, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and influenza A virus antigens. In homeopathic practice, these ingredients are traditionally used to support immune response to viral infections, though homeopathic products are not evaluated by the FDA for safety or effectiveness. This product is marketed based on homeopathic tradition rather than established clinical evidence.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
43742-2123-01 43742-2123-1 You're viewing this Main listing 30 mL in 1 BOTTLE, DROPPER (43742-2123-1) 2024-01-25 Mar 20, 2029 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Vir Combination 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; 5 18 [hp_X]/mL; 1 12 [hp_X]/mL; 2 12 [hp_X]/mL; 4 16 [hp_C]/mL; 33 [hp_X]/mL; 6this 43742-2123-01 Deseret 30 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Jan 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDeseret Biologicals, Inc.
Labeler code43742
First marketedJan 2024
Product typeHuman Otc Drug
Portfolio617 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 47 words ▾

USES: • For the temporary relief of symptoms including: • Cold Symptoms • Fever Fatigue • Muscle Aches and Pains • Headache • Rash • Herpes • Flu Symptoms These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

⏱️ Dosage and Administration 29 words ▾

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

⚠️ Warnings 45 words ▾

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

🧪 Active Ingredient 68 words ▾

ACTIVE INGREDIENTS: Adenoviren Nosode 12C, 30C, 60C, 200C, Cytomegalovirus Nosode 18X, 30X, 60X, 200X, DNA 12X, 15X, 30X, 60X, 200X, 12C, 30C, 60C, 200C, Epstein-Barr Virus Nosode 16C, 30C, 60C, 200C, Hepatitis B Nosode 33X, 60X, 200X, Herpes Simplex 1 & 2 Nosode 15X, 30X, 60X, 200X , Human Herpesvirus 6A 15X, 30X, 60X, 200X, Human Herpesvirus 6B 15X, 30X, 60X, 200X, Influenzinum 12X, 15X, 30X, 60X, 200X.

🧪 Inactive Ingredients 6 words ▾

INACTIVE INGREDIENTS: Demineralized water, 25% ethanol

🎯 Purpose 52 words ▾

PURPOSE: Adenoviren Nosode – Cold Symptoms, Cytomegalovirus Nosode - Headache, DNA - Fatigue, Muscle Aches and Pain, Epstein-Barr Virus Nosode - Fever, Hepatitis B Nosode – Muscle Aches and Pains, Herpes Simplex 1 & 2 Nosode - Rash, Human Herpesvirus 6A - Herpes, Human Herpesvirus 6B - Fatigue, Influenzinum – Flu Symptoms.

📄 Keep Out of Reach of Children 19 words ▾

KEEP OUT OF REACH OF CHILDREN: In case of overdose, contact a physician or Poison Control Center right away.

📄 Questions or Comments 15 words ▾

QUESTIONS: Dist. By: Deseret Biologicals, Inc. 469 W. Parkland Drive Sandy, UT 84070 www.desbio.com 800-827-8204

📄 Package Label / Principal Display Panel 15 words ▾

PACKAGE LABEL DISPLAY: DesBio VIR: Combination Homeopathic NDC 43742-2123-1 1 FL OZ (30 ml) VIR:Combination

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Vir Combination Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2 4 STRAIN CL-68578 ANTIGEN 12 [hp_C]/mL; 5 18 [hp_X]/mL; 1 12 [hp_X]/mL; 2 12 [hp_X]/mL; 4 16 [hp_C]/mL; 33 [hp_X]/mL; 6 LIQUID is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 43742-2123-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 43742-2123-01, written without dashes as 43742212301. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 43742-2123-01, the first segment (43742) is the labeler code FDA assigned to Deseret Biologicals, Inc.; the middle segment (2123) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Deseret Biologicals, Inc. has reported a marketing end date of 2029-03-20, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Deseret Biologicals, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 43742-2122-01 · Deseret 43742-2124-01 · Deseret →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.